Excitatory amino acid antagonists as novel anticonvulsants.
D000600:Amino Acids, Dicarboxylic / Q000037:antagonists & inhibitors*; D000818:Animals; D000927:Anticonvulsants; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors; D004827:Epilepsy / Q000188:drug therapy*; D005971:Glutamates / Q000494:pharmacology; D007608:Kainic Acid / Q000037:antagonists & inhibitors; D016202:N-Methylaspartate; D009410:Nerve Degeneration; D009422:Nervous System Diseases / Q000188:drug therapy; D010069:Oxadiazoles / Q000037:antagonists & inhibitors; D016318:Quisqualic Acid; D017459:Receptors, Amino Acid; D011956:Receptors, Cell Surface / Q000187:drug effects; D013329:Structure-Activity Relationship
D000600:Amino Acids, Dicarboxylic; D000927:Anticonvulsants; D005971:Glutamates; D010069:Oxadiazoles; D017459:Receptors, Amino Acid; D011956:Receptors, Cell Surface; D001224:Aspartic Acid; D016202:N-Methylaspartate; D016318:Quisqualic Acid; D007608:Kainic Acid